Skip to main content

Antonio Julia Cano

Institutions of which they are part

Head of group
Rheumatology
Vall Hebron Institut de Recerca

Antonio Julia Cano

Institutions of which they are part

Head of group
Rheumatology
Vall Hebron Institut de Recerca

Projects

PROYECTO IMID-Ab: Personalización del tratamiento anti-TNF en Artritis Reumatoide en base a la inmunogeneicidad

IP: Sara Marsal Barril
Collaborators: Antonio Julia Cano, Raul Tortosa Mendez, Elena Granell Pallares
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 129203
Reference: RTC-2014-2920-1
Duration: 03/02/2014 - 02/02/2017

Biomarcadores matabolómicos de actividad en Artritis Reumatoide y Artritis Psoriásica

IP: Antonio Julia Cano
Collaborators: Maria America Lopez Lasanta
Funding agency: Instituto de Salud Carlos III
Funding: 81070
Reference: PI12/01362
Duration: 01/01/2013 - 31/12/2016

Proyecto IMID-Inc, "Biobanco IMIDs diferencial permite identificar biomarcadores y nuevas terapias"

IP: Sara Marsal Barril
Collaborators: Nuria Palau Balaña, Antonio Julia Cano, Raul Tortosa Mendez, Elena Granell Pallares, Maria America Lopez Lasanta
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 2058749
Reference: IPT-010000-2010-36
Duration: 17/11/2010 - 31/08/2013

Ministerio de Ciencia

Desarrollo de un kit diagnóstico para las enfermedades inflamatorias mediadas por mecanismos inmunes (IMID-Kit). Projecte: PSE-010000-2008-9 Subprojectes: PSE 010000-2008-036 i PSE 010000-2008-039 importe concedido 4.002.822 €

IP: Sara Marsal Barril
Collaborators: Antonio Julia Cano, Raul Tortosa Mendez, Elena Granell Pallares
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 2854937.08
Reference: PSE-010000-2009-001
Duration: 23/07/2009 - 31/03/2011

Ministerio de Ciencia

Related news

The head of the Rheumatology Service at Vall d'Hebron University Hospital and of the Rheumatology research group at VHIR is a highly accomplished rheumatologist with a distinguished career in the field.

It is the first international multi-centre clinical trial to analyse the safety and effect of this treatment for an autoimmune disease.

Els estudis avançaran en els camps de les malalties digestives, el VIH, la fatiga crònica, les patologies cardíaques, l’hepatitis, la diabetis i l’oftalmologia.

Related professionals

Rosa Mejon Berges

Rosa Mejon Berges

Read more
Carmen Simon-Talero Peña

Carmen Simon-Talero Peña

Research Group of Physical Medicine and Rehabilitation
Read more
Albert Barberà LLuis

Albert Barberà LLuis

Director/a d'Àrea
Core Facilities Area
Read more
Emma Bigas Alsina

Emma Bigas Alsina

Research technician
Liver Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.